BIOMAT Database Logo BIOMAT Database Logo

Effects of elevated serum insulinlike growth factor-II on growth hormone and insulinlike growth factor-I mRNA and secretion. 1989

D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Department of Pediatrics, Medicine, and Laboratory Animal Medicine, Stanford University, CA.

The insulinlike growth factors (IGF) appear to exert feedback control over their own production. In an effort to determine the physiologic mechanisms for this feedback modulation, we utilized a previously developed in vivo model in which rIGF-II secreting tumor cells are transplanted into immunodeficient rats to form IGF-II secreting tumors. The tumor-bearing rat have serum IGF-II concentrations sevenfold greater than those in controls (119 +/- 16 ng/mL [mean +/- SE] v 17 +/- 2 ng/mL, P less than .0001). Serum IGF-I concentrations were reduced among the tumor-bearing rats (438 +/- 42 ng/mL v 606 +/- 32 ng/mL, P = .002) and were negatively correlated with IGF-II concentrations (r = -.47, P = .025), suggesting that IGF-II suppressed the secretion of IGF-I. Increased serum IGF-II concentrations, however, did not affect basal growth hormone concentrations (tumor-bearing, 44 +/- 12 ng/mL; control 33 +/- 6 ng/mL, P = 0.96). The GH response to GH releasing factor was likewise similar in both groups. Moreover, pituitary GH mRNA level were not different in the two groups, suggesting that IGF-II does not have a significant effect on GH secretion in this in vivo model. There was no association between serum glucose and serum IGF-I or IGF-II concentrations. To examine the effect of IGF-II on IGF-I production from the liver, we measured IGF-I mRNA levels in a subset of animals. Despite these differences in serum IGF-I concentrations, the tumor-bearing rats did not have significantly lower liver IGF-I mRNA levels.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007335 Insulin-Like Growth Factor II A well-characterized neutral peptide believed to be secreted by the LIVER and to circulate in the BLOOD. It has growth-regulating, insulin-like and mitogenic activities. The growth factor has a major, but not absolute, dependence on SOMATOTROPIN. It is believed to be a major fetal growth factor in contrast to INSULIN-LIKE GROWTH FACTOR I, which is a major growth factor in adults. IGF-II,Multiplication-Stimulating Activity,Somatomedin MSA,IGF-2,Insulin Like Growth Factor II,Insulin-Like Somatomedin Peptide II,Multiplication-Stimulating Factor,Somatomedin A,Factor, Multiplication-Stimulating,Insulin Like Somatomedin Peptide II,Multiplication Stimulating Activity,Multiplication Stimulating Factor
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009384 Paraneoplastic Endocrine Syndromes Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion. Ectopic Hormone Syndromes,Ectopic Hormone Syndrome,Endocrine Syndrome, Paraneoplastic,Paraneoplastic Endocrine Syndrome,Syndrome, Ectopic Hormone,Syndrome, Paraneoplastic Endocrine,Syndromes, Ectopic Hormone,Syndromes, Paraneoplastic Endocrine
D011923 Rats, Nude A mutant strain of Rattus norvegicus without a thymus and with depressed or absent T-cell function. This strain of rats may have a small amount of hair at times, but then lose it. Athymic Rats,Nude Rats,Rats, Athymic,Athymic Rat,Nude Rat,Rat, Athymic,Rat, Nude
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005246 Feedback A mechanism of communication within a system in that the input signal generates an output response which returns to influence the continued activity or productivity of that system. Feedbacks
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Growth hormone-insulinlike growth factor I and immune function.
April 1993, Trends in endocrinology and metabolism: TEM,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Effects of growth hormone and insulinlike growth factor-I on body growth and adult bone metabolism.
July 2000, Current opinion in rheumatology,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells.
August 1991, The Journal of clinical investigation,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Serum insulinlike growth factor-I in biliary atresia.
February 2003, Journal of pediatric surgery,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Effects of insulinlike growth factor binding proteins on insulinlike growth factor-I biodistribution in tumor-bearing nude mice.
February 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Somatomedin-C/insulinlike growth factor I (Sm-C/IGF-I) and insulinlike growth factor II (IGF-II) mRNAs during lung development in the rat.
January 1988, Experimental lung research,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Preventive effects of insulinlike growth factor-I on steroid-induced muscle atrophy.
February 1999, Muscle & nerve,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Growth hormone secretion during sleep. II. Interrelationships between growth hormone secretion, insulin-like growth factor I and sex steroids.
January 1990, Hormone research,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Growth hormone bioactivity and levels of growth hormone, growth hormone-binding protein, insulinlike growth factor I, and insulinlike growth factor-binding proteins in premature and full-term newborns during the first month of life.
February 1997, Archives of pediatrics & adolescent medicine,
D M Wilson, and S N Perkins, and J A Thomas, and S Seelig, and S A Berry, and T E Hamm, and A R Hoffman, and R L Hintz, and R G Rosenfeld
Insulinlike growth factor I and the kidney.
April 1996, Trends in endocrinology and metabolism: TEM,
Copied contents to your clipboard!